The rise in the use and advancement of biologics and personalized medicine, along with a shift towards home-based treatments, is driving a surge in the production and innovation of drug delivery systems. This trend is further fueled by the increasing demand for data collection technologies and connectivity.
Download the eBook
Biologics and personalized medicine play a crucial role, both directly and indirectly, in advancing the development of injection devices, their associated interfaces for patients and doctors, and the testing equipment required for design verification and device release.
The need for parenteral drug administration, improved bioavailability, and innovative therapeutic options—including those suited for home-based treatments—drives the demand for delivery systems that adhere to industry standards and integrate modern technology.
According to a report by Mordor Intelligence, the biologics market is projected to grow from USD 401 billion in 2023 to USD 562 billion by 2028, with a compound annual growth rate (CAGR) of 6.96 % during this period.
This growth is driven by factors such as the COVID-19 pandemic, an increase in chronic diseases, and the development of new therapies for conditions like cancer, autoimmune diseases, and neurological disorders.
The outlook remains strong as personalized and immunotherapies advance, but the development, manufacturing, and testing of both the drug products and their delivery systems are complex and come with high expectations.
This ebook explores the important breakthroughs defining the rapidly evolving field of drug delivery systems, which are being driven by biologics, customized medicine, the trend toward home-based therapy, and the rising relevance of connection and data-collecting technology. These changes are fundamentally changing drug delivery device manufacture and innovation, as well as establishing new criteria for materials testing.
Divided into sections that focus on three dominating trends:
- The growing importance of biologics and personalized medicine.
- The increasing shift toward in-home healthcare.
- The evolving connected device landscape associated with today´s therapy systems.
We will also examine how manufacturers of materials and component testing machinery are preparing for emerging advancements. This includes their collaboration with standards committees and their ongoing efforts to enhance testing equipment, ensuring it supports the production and quality assurance of these advanced pharmaceutical devices.
To summarize, this eBook gives a detailed overview of the present trends affecting the drug delivery system landscape, the vital role of materials testing in guaranteeing device quality and safety, and the ever-changing field's future trajectory.
Download the eBook
Download the full eBook now to explore in-depth insights on the latest advancements in injection devices, device connectivity, and materials testing, and discover how manufacturers are evolving their testing equipment to meet the demands of advanced pharmaceutical technologies.
This information has been sourced, reviewed, and adapted from materials provided by ZwickRoell GmbH Co. KG.
For more information on this source, please visit ZwickRoell GmbH Co. KG.